Citizen Portal
Sign In

Get Full Government Meeting Transcripts, Videos, & Alerts Forever!

Get email alerts on the Healthcare Finance topic

No spam. Unsubscribe anytime.

WinMed leaders report record revenues, warn Medicaid-directed payments may decline

Winneshiek County Board of Supervisors · October 27, 2025
AI-Generated Content: All content on this page was generated by AI to highlight key points from the meeting. For complete details and context, we recommend watching the full video. so we can fix them.

Summary

WinMed trustees and finance staff told the Winneshiek County Board their health system posted strong operating revenues last year—driven in part by an annual Medicaid directed payment program—while flagging higher capital spending, increased bad debt and a future reduction in that Medicaid benefit unless policy changes occur.

WinMed presenters gave the Winneshiek County Board an overview of the health system’s financial year, reporting growth in patient revenue, major capital spending and caution about the long-term outlook for one federal/state funding stream.

Presenters said WinMed’s operations produced a substantial improvement in net position last year. Key figures presented included roughly $28 million in capital asset spending for the year, operating revenues surpassing $100 million, and operating income reported at about $3.6 million (roughly a 3.5% margin). The presenters also noted about 115 days of cash on hand at year-end.

A large element of the year’s improvement came from Iowa’s Medicaid directed payment program, which presenters said unlocked federal funds and provided an additional net benefit of several million dollars (the presenters described prior-year figures of about $4.3 million and a higher current estimate tied to the program). They cautioned the board that the program must be reapproved periodically by the Centers for Medicare & Medicaid Services and that statutory changes will likely reduce that program’s benefit gradually through 2032 unless new policy action is taken.

Presenters described other revenue drivers: higher volumes across surgery, the emergency department, radiology and lab; the opening of a retail pharmacy as a new service line; and recruitment of new physicians and specialties (urology, rheumatology, dermatology and additional general surgery capacity). They noted an unusually large capital year tied to the “transforming tomorrow” building project and said debt financing includes USDA loans and local bank financing to complete construction.

Board members pressed presenters on collection challenges and increasing bad debt, attributing part of the difficulty to denials from Medicare Advantage and private insurers. Presenters said the organization is considering stepped-up front-end collections (copay collection and patient payment plans), while remaining mindful of access and affordability.

Presenters also described a recent facility-design choice, called an “on stage/off stage” layout that separates patient corridors from staff work areas. They said early feedback from staff and patients in the newly opened upper level has been positive, though the design increases construction costs.

No formal action was required on the presentation itself. The board later accepted WinMed’s audit and directed staff to file it (see actions).